Ultragenyx Pharmaceutical (RARE) Q3 2022 Earnings

28JulConfirmed
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-2.26
-1.87
-1.47
-1.08

Details

Expected EPS
-1.74
Actual EPS
-2.26
Surprise EPS
-0.52
Surprise Percent
+29.89%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -2.26 per share for Q3 2022.

0 Comments

Share your thoughts